Recognition for NADMED technology
NADMED is one of ten companies chosen for the Deep Tech Accelerator Funding program. The companies...
Meet NADMED at EUROMIT 2023
NADMED attends the premier international conference on mitochondrial disease EUROMIT 11-15 June....
Niacin counteracting cancer cachexia – NADMED used for measuring
A recent study with mice suggests NAD+ repletion with niacin counteracts cancer cachexia. The...